To purchase hard copies of this book, please email:
orders@intechopen.com
Share this page
This book is indexed in
Medicine » Immunology, Allergology and Rheumatology
Autoimmune Disorders - Current Concepts and Advances from Bedside to Mechanistic Insights
Edited by Fang-Ping Huang, ISBN 978-953-307-653-9, Hard cover, 614 pages, Publisher: InTech, Chapters published November 14, 2011 under CC BY 3.0 license
DOI: 10.5772/1851
Autoimmune disorders are caused due to break down of the immune system, which consequently fails in its ability to differentiate "self" from "non-self" in the context of immunology. The diseases are intriguing, both clinically and immunologically, for their diversified clinical phenotypes and complex underlying immunological mechanisms. This book offers cutting-edge information on some of the specific autoimmune disease phenotypes, respective diagnostic and prognostic measures, classical and new therapeutic options currently available, pathogenesis and underlying mechanisms potentially involved, and beyond. In the form of Open Access, such information is made freely available to clinicians, basic scientists and many others who will be interested regarding current advances in the areas. Its potential readers will find many of the chapters containing in-depth analysis, interesting discussions and various thought-provoking novel ideas.
- Chapter 1
Autoimmune Disorders Associated to Type 1 Diabetes Mellitus in Children and Adolescents - Chapter 2
Hashimoto's Thyroiditis in Children and Adolescents - Chapter 3
Primary Sjögren’s Syndrome: Current Pathophysiological, Diagnostic and Therapeutic Advances - Chapter 4
Changing Spectrum of Chronic Immune Thrombocytopenic Purpura: New Face for an Old Disease - Chapter 5
Autoimmune-Associated Hemophagocytic Syndrome/Macrophage Activation Syndrome - Chapter 6
Ocular Myasthenia Analysis of Diagnostic and Treatment Options - Chapter 7
Sweet Syndrome - Chapter 8
Validation of Protein Biomarkers to Advance the Management of Autoimmune Disorders - Chapter 9
Relevance of Autoantibodies for the Classification and Pathogenesis of Neurological Diseases - Chapter 10
Preclinical and Predictive Algorithms in Monitoring Patients with Autoimmune Diseases and Their Relatives-at-Risks - Chapter 11
Application of Novel Quantitative Proteomic Technologies to Identify New Serological Biomarkers in Autoimmune Diseases - Chapter 12
Application of Monoclonal Antibody Therapies in Autoimmune Diseases - Chapter 13
The Emerging Role of Monoclonal Antibodies in the Treatmentof Systemic Lupus Erythematosus - Chapter 14
Treatment of Pediatric-Onset Lupus Nephritis: A New Option of Less Cytotoxic Immunosuppressive Therapy - Chapter 15
Recent Advances in the Treatment of Neurological Autoimmune Disorders - Chapter 16
Synthetic Glucocorticoids Modulate Function of Neural Cells: Implications in Autoimmune Neurological Disorders - Chapter 17
Intravenous Immunoglobulins in Neurological Diseases: Established and Novel Clinical Applications - Chapter 18
Cellular Based Therapies for the Treatment of Multiple Sclerosis - Chapter 19
Haematopoietic Cell Transplantation and Immunotherapy for Autoimmune Diseases in Children and Adults - Chapter 20
Thionamides-Related Vasculitis in Autoimmune Thyroid Disorders: Review of Current Literature and Case Reports - Chapter 21
The Ectopic Germinal Centre Response in Autoimmune Disease and Cancer - Chapter 22
Myasthenia Gravis: New Insights into the Effect of MuSK Antibodies and Acetylcholinesterase Inhibitors - Chapter 23
Vasoactive Neuropeptides in Autoimmune Diseases - Chapter 24
Antibody-Proteases in the Pathogenesis of Autoimmune Demyelination and Monitoring Patients with Multiple Sclerosis - Chapter 25
Role of Fatty Acids in the Resolution of Autoimmune and Inflammatory Diseases - Chapter 26
Autoimmune Disorder and Autism - Chapter 27
Chronobiology of and Chronotherapy for Rheumatoid Arthritis - Chapter 28
Four Aspects of Autoimmunity and How to Regain Tolerance to Self From an Autoimmune Disease Utilizing the Modified Vaccination Technique - Chapter 29
Parasitic Helminths as Potential Therapeutic Agents Against Autoimmune Disorders


